Christa L. Pawlowski
Research Subjects
Christa L. Pawlowski has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Anirban Sen Gupta
Case Western Reserve University
2 shared publications Alexander Dornback
Haima Therapeutics LLC Cleveland OH USA
1 shared publicationAndrew Ditto
Haima Therapeutics LLC Cleveland OH USA
1 shared publicationBaylee Traylor
Haima Therapeutics LLC Cleveland OH USA
1 shared publicationBipin Chakravarthy Paruchuri
Case Western Reserve University Department of Biomedical Engineering Cleveland OH USA
1 shared publicationDante Disharoon
Case Western Reserve University Department of Biomedical Engineering Cleveland OH USA
1 shared publication
Latest Publications
- 2 July 2026
- Published by Springer Nature
- p. 325-329
SynthoPlate and Related Platelet-Inspired Synthetic Nanotechnologies for Hemorrhage Control
- 2 July 2026
- Published by Springer Nature
- p. 325-329
SynthoPlate and Related Platelet-Inspired Synthetic Nanotechnologies for Hemorrhage Control
- Open Access
- 20 April 2026
- Published by Wiley in Advanced Science
- Vol. 13 (38) , e00002
Lyophilized Synthetic Platelets: In Vitro Characterization and In Vivo Evaluation in Mouse Thrombocytopenia Model
Platelet transfusions to treat bleeding complications use donor‐derived platelets stored at room‐temperature, that have a shelf‐life of only 5–7 days due to bacterial contamination risks. Cold‐stored and freeze‐dried platelets are being investigated for extending shelf‐life, but these still have the inherent challenge of donor‐dependency. To address this, we developed a liposome‐based synthetic platelet (SP) nanoconstruct that mimics the primary hemostatic mechanisms of platelets, and have previously reported its efficacy. However, a logistical limitation of SP is its susceptibility to environment‐induced physico‐chemical instabilities that reduces shelf‐life when stored as aqueous suspension, impacting its availability and bioactivity. Lyophilization of liposomal nanotherapeutics utilizing anhydrobiosis‐inspired lyoprotectants can enhance shelf‐life, but this has not been explored for synthetic platelets. With these considerations, we report advancing SP into a lyophilized product (Lyo‐SP) that can be rapidly aqueous‐reconstituted for on‐demand use. Lyo‐SP retained morphology, size, and charge in long‐term storage at various temperatures, and conserved platelet‐mimetic functions in multiparametric assays with human plasma and blood. Lyo‐SP demonstrated biosafety in its effect analysis on endothelial cells, neutrophils, RBCs and complement C3. Lyo‐SP significantly reduced bleeding in a tail‐clip model in thrombocytopenic mice. These studies establish the potential of Lyo‐SP as a shelf‐stable platelet surrogate for treating bleeding complications.
- 20 April 2026
- Published by Wiley in Advanced Science
- Vol. 13 (38) , e00002
Open AccessLyophilized Synthetic Platelets: In Vitro Characterization and In Vivo Evaluation in Mouse Thrombocytopenia Model
Platelet transfusions to treat bleeding complications use donor‐derived platelets stored at room‐temperature, that have a shelf‐life of only 5–7 days due to bacterial contamination risks. Cold‐stored and freeze‐dried platelets are being investigated for extending shelf‐life, but these still have the inherent challenge of donor‐dependency. To address this, we developed a liposome‐based synthetic platelet (SP) nanoconstruct that mimics the primary hemostatic mechanisms of platelets, and have previously reported its efficacy. However, a logistical limitation of SP is its susceptibility to environment‐induced physico‐chemical instabilities that reduces shelf‐life when stored as aqueous suspension, impacting its availability and bioactivity. Lyophilization of liposomal nanotherapeutics utilizing anhydrobiosis‐inspired lyoprotectants can enhance shelf‐life, but this has not been explored for synthetic platelets. With these considerations, we report advancing SP into a lyophilized product (Lyo‐SP) that can be rapidly aqueous‐reconstituted for on‐demand use. Lyo‐SP retained morphology, size, and charge in long‐term storage at various temperatures, and conserved platelet‐mimetic functions in multiparametric assays with human plasma and blood. Lyo‐SP demonstrated biosafety in its effect analysis on endothelial cells, neutrophils, RBCs and complement C3. Lyo‐SP significantly reduced bleeding in a tail‐clip model in thrombocytopenic mice. These studies establish the potential of Lyo‐SP as a shelf‐stable platelet surrogate for treating bleeding complications.